|1.||Bi, Yan-Jing: 1 article (05/2015)|
|2.||Liu, Xiao-Yu: 1 article (05/2015)|
|3.||Ning, Cheng-Qing: 1 article (05/2015)|
|4.||Liu, Li-Fei: 1 article (05/2015)|
|5.||Hu, Liang: 1 article (05/2015)|
|6.||Yao, Lei: 1 article (05/2015)|
|7.||Lu, Cheng: 1 article (05/2015)|
|8.||He, Yu-Jun: 1 article (05/2015)|
|9.||Yu, Nie-Fang: 1 article (05/2015)|
|10.||Jain, D K: 1 article (01/2013)|
05/05/2015 - "Macrocyclic compounds as anti-cancer agents: design and synthesis of multi-acting inhibitors against HDAC, FLT3 and JAK2."
01/01/2013 - "The present article summarizes current status of different peptide based macrocyclic compounds being developed as HDACi for the treatment of cancer."
08/01/2008 - "Two synthetic hexaoxazole-containing macrocyclic compounds (HXDV and HXLV-AC) have been characterized with regard to their cytotoxic activities versus human cancer cells, as well as the mode, thermodynamics, and specificity with which they bind to the intramolecular (3+1) G-quadruplex structural motif formed in the presence of K+ ions by human telomeric DNA. "
|1.||Photosensitizing Agents (Photosensitizers)
|4.||DNA (Deoxyribonucleic Acid)
|1.||Photochemotherapy (Photodynamic Therapy)